A. Gürbüz, U. Yetkin, C. Özbek, O. Gokalp, smail Yürekli, A. Çall, N. Postac, Murat Ye il
Pericardial diseases imitate more common cardiac diseases and therefore can be difficult to diagnose. We describe a case of idiopathic chronic hemorrhagic pericarditis. A pragmatic clinical and scientific approach for improved diagnosis of pericardial diseases is outlined
{"title":"Idiopathic Chronic Hemorrhagic Pericarditis","authors":"A. Gürbüz, U. Yetkin, C. Özbek, O. Gokalp, smail Yürekli, A. Çall, N. Postac, Murat Ye il","doi":"10.5580/169e","DOIUrl":"https://doi.org/10.5580/169e","url":null,"abstract":"Pericardial diseases imitate more common cardiac diseases and therefore can be difficult to diagnose. We describe a case of idiopathic chronic hemorrhagic pericarditis. A pragmatic clinical and scientific approach for improved diagnosis of pericardial diseases is outlined","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114343168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
U. Yetkin, K. Erguneş, Aykut Şahin, I. Yurekli, A. Gürbüz
Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population including other cardiovascular diseases.In this study we present our strategy of coronary bypass procedure in a case with bicuspid aortic valve and mild dilation of ascending aorta.
{"title":"Our strategy of coronary bypass procedure in a case with bicuspid aortic valve and mild dilation of ascending aorta","authors":"U. Yetkin, K. Erguneş, Aykut Şahin, I. Yurekli, A. Gürbüz","doi":"10.5580/1398","DOIUrl":"https://doi.org/10.5580/1398","url":null,"abstract":"Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population including other cardiovascular diseases.In this study we present our strategy of coronary bypass procedure in a case with bicuspid aortic valve and mild dilation of ascending aorta.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"86 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124841053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Aksun, A. Gürbüz, Ufuk Yetk n, Ertan Damar, Banu Lafç, A. Özelçi, T. Goktogan, N. Karahan
Levosimendan (LS), a new inodilator used in the treatment of decompensate heart failure, has been reported to be effective in patients with high perioperative risks, with abnormal left ventricular function, and who face difficulties in weaning off cardiopulmonary bypass. Cause of its many beneficial effects, the use of LS in cardiac surgery arises. However, experiences about the use of LS in pediatric patients are limited. We administered LS in a case of 3 years old child who developed heart failure during cardiopulmonary bypass removal period. A 3 years old, 11 kg female child was admitted in our center who had a total revision of tetralogy of Fallot four months ago. Any postoperative complaints or symptoms were not present since we find out a large progressive aneurysm in the echocardiographic evaluation of the otogen pericardial patch which was prepared with gluteraldehide. Induction of anesthesia was done with 2 mg/kg ketamin and 0.5 mg/kg atracurium, 20μg/kg atropin was administered also. After endotracheal entubation, invasive blood pressure of the left radial artery and central venous pressure monitoring of the right internal jugular vein was successfully. After the excision of the pericardial patch, the repair of the right ventricular outflow was done with e-PTFE graft. At the end of cardiopulmonary bypass (CPB) surgery deep hypotension occurred. In spite of dopamine (15 μg/kg/min), dobutamine (15μg/kg/min) and adrenalin (1mg/h) infusions, myocardium failed to maintain normotension. Diuresis was suboptimal in our patient also. Upon these LS infusion was started with the loading dose of 12 μg/kg over 10 minutes. Later, 0.2 μg/kg/min maintenance dosage was applied. In an hour we observed 200 cc diuresis and the vital signs were taken under control. LV infusion was completed after 24 hours postoperatively in our intensive care unit. Six hours later we started to reduce the analogous inotropic support (dopamine 10μg/kg/min, dobutamine 10μg/kg/min, adrenalin 0.5mg/h) since the hemodynamic parameters were satisfactory. Twelve hours later another reduction was applied. Since the well tolerance of the myocardium, we were able to stop the other inotropic drug infusions after 48 hours and the patient was discharged from the hospital 10 days after the surgery. Our clinical experiences with LS has shown that it reduces conventional inotropic agents dosages and could be a satisfactory agent in myocardial depression therapy which occurred in CPB surgery intraoperatively also in pediatric patients. However the need for serial randomized controlled studies in pediatric patient about the use of LS is indisputable.
{"title":"Using Of Levosimendan In A Redo Cardiac Pediatric Operation","authors":"M. Aksun, A. Gürbüz, Ufuk Yetk n, Ertan Damar, Banu Lafç, A. Özelçi, T. Goktogan, N. Karahan","doi":"10.5580/126","DOIUrl":"https://doi.org/10.5580/126","url":null,"abstract":"Levosimendan (LS), a new inodilator used in the treatment of decompensate heart failure, has been reported to be effective in patients with high perioperative risks, with abnormal left ventricular function, and who face difficulties in weaning off cardiopulmonary bypass. Cause of its many beneficial effects, the use of LS in cardiac surgery arises. However, experiences about the use of LS in pediatric patients are limited. We administered LS in a case of 3 years old child who developed heart failure during cardiopulmonary bypass removal period. A 3 years old, 11 kg female child was admitted in our center who had a total revision of tetralogy of Fallot four months ago. Any postoperative complaints or symptoms were not present since we find out a large progressive aneurysm in the echocardiographic evaluation of the otogen pericardial patch which was prepared with gluteraldehide. Induction of anesthesia was done with 2 mg/kg ketamin and 0.5 mg/kg atracurium, 20μg/kg atropin was administered also. After endotracheal entubation, invasive blood pressure of the left radial artery and central venous pressure monitoring of the right internal jugular vein was successfully. After the excision of the pericardial patch, the repair of the right ventricular outflow was done with e-PTFE graft. At the end of cardiopulmonary bypass (CPB) surgery deep hypotension occurred. In spite of dopamine (15 μg/kg/min), dobutamine (15μg/kg/min) and adrenalin (1mg/h) infusions, myocardium failed to maintain normotension. Diuresis was suboptimal in our patient also. Upon these LS infusion was started with the loading dose of 12 μg/kg over 10 minutes. Later, 0.2 μg/kg/min maintenance dosage was applied. In an hour we observed 200 cc diuresis and the vital signs were taken under control. LV infusion was completed after 24 hours postoperatively in our intensive care unit. Six hours later we started to reduce the analogous inotropic support (dopamine 10μg/kg/min, dobutamine 10μg/kg/min, adrenalin 0.5mg/h) since the hemodynamic parameters were satisfactory. Twelve hours later another reduction was applied. Since the well tolerance of the myocardium, we were able to stop the other inotropic drug infusions after 48 hours and the patient was discharged from the hospital 10 days after the surgery. Our clinical experiences with LS has shown that it reduces conventional inotropic agents dosages and could be a satisfactory agent in myocardial depression therapy which occurred in CPB surgery intraoperatively also in pediatric patients. However the need for serial randomized controlled studies in pediatric patient about the use of LS is indisputable.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"13 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129908601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Özbek, Ufuk Yetk n, B. Ozcem, smail Yürekl, A. Gürbüz
Endocarditis is a rare and the most fatal complication of brucellosis and can cause severe cardiac injuries.Generally aortic valve invasion is seen.We describe a case of Complicated brucella endocarditis of the aortic valve.
{"title":"Complicated brucella endocarditis of the aortic valve","authors":"C. Özbek, Ufuk Yetk n, B. Ozcem, smail Yürekl, A. Gürbüz","doi":"10.5580/97c","DOIUrl":"https://doi.org/10.5580/97c","url":null,"abstract":"Endocarditis is a rare and the most fatal complication of brucellosis and can cause severe cardiac injuries.Generally aortic valve invasion is seen.We describe a case of Complicated brucella endocarditis of the aortic valve.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"51 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128344491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
U. Yetkin, K. Erguneş, A. Özelçi, T. Goktogan, A. Gürbüz
Magnetic resonance angiography (MRA) has recently become instrumental in the diagnosis of arterial disease and is gaining an important role in the study of plaining revascularization.In this study we present clinical utility of magnetic resonance angiography for femoro-popliteal arterial occlusive disease.
{"title":"Clinical utility of magnetic resonance angiography for femoro-popliteal arterial occlusive disease","authors":"U. Yetkin, K. Erguneş, A. Özelçi, T. Goktogan, A. Gürbüz","doi":"10.5580/14a0","DOIUrl":"https://doi.org/10.5580/14a0","url":null,"abstract":"Magnetic resonance angiography (MRA) has recently become instrumental in the diagnosis of arterial disease and is gaining an important role in the study of plaining revascularization.In this study we present clinical utility of magnetic resonance angiography for femoro-popliteal arterial occlusive disease.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128406292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Idemudia, E. Ugwuja, O. Afonja, Idogun Es, N. Ugwu
C-reactive protein (CRP), a biomarker of inflammation, has been found to play a role in the pathogenesis of cardiovascular disease and its determination has been proposed as one method of improving the prediction of the risk of cardiovascular events. CRP was determined in 150 hypertensive patients aged 30-59 years and 30 apparently healthy normotensive individuals matched for age and socioeconomic status by ELISA technique. Atherogenic index (LDL-C/HDL-C) and coronary heart disease risk (HDL-C/TC) were also calculated from the lipid profile. Among the hypertensive patients, only 1 (1.2%) female had a dangerous coronary heart disease risk, while 14 (9.3%) (6 males and 8 females) were at high risk of CHD and only 16 (10.7%) (11 males and 5 females) had probable protection against CHD. Hypertensive patients were significantly (p < 0.05) heavier than the normotensive patients (28.34 ± 4.40kg/m vs. 25.79 ± 2.91kg/m), with significantly higher atherogenic indices and CRP. Among the hypertensive patients, CRP positively correlated with atherogenic index (r = 0.551, p < 0.05) and CHD risk (r = 0.589, p < 0.05). However, in normotensive patients, CRP was positively correlated with atherogenic index (r = 0.492, p < 0.01) but negatively correlated with CHD risk (r = -0.475, p < 0.01). In conclusion, hypertensive Nigerians have significantly higher CRP than their normotensive counterparts, which correlates with CHD risk.
c反应蛋白(CRP)是炎症的生物标志物，在心血管疾病的发病机制中起着重要作用，其测定已被提出作为改善心血管事件风险预测的一种方法。采用酶联免疫吸附试验(ELISA)对150例30 ~ 59岁的高血压患者和30例年龄和社会经济状况相匹配的表面健康正常人群进行CRP测定。根据脂质谱计算动脉粥样硬化指数(LDL-C/HDL-C)和冠心病风险(HDL-C/TC)。在高血压患者中，仅有1例(1.2%)女性有冠心病危险，14例(9.3%)(男性6例，女性8例)有冠心病高危，仅有16例(10.7%)(男性11例，女性5例)有可能预防冠心病。高血压患者的体重(28.34±4.40kg/m vs. 25.79±2.91kg/m)显著高于正常患者(p < 0.05)，其动脉粥样硬化指数和CRP均显著高于正常患者。在高血压患者中，CRP与动脉粥样硬化指数(r = 0.551, p < 0.05)、冠心病风险(r = 0.589, p < 0.05)呈正相关。而在血压正常的患者中，CRP与动脉粥样硬化指数呈正相关(r = 0.492, p < 0.01)，与冠心病风险呈负相关(r = -0.475, p < 0.01)。综上所述，尼日利亚高血压患者的CRP水平明显高于正常者，这与冠心病风险相关。
{"title":"C-Reactive Proteins and Cardiovascular Risk Indices in Hypertensive Nigerians.","authors":"J. Idemudia, E. Ugwuja, O. Afonja, Idogun Es, N. Ugwu","doi":"10.5580/fa9","DOIUrl":"https://doi.org/10.5580/fa9","url":null,"abstract":"C-reactive protein (CRP), a biomarker of inflammation, has been found to play a role in the pathogenesis of cardiovascular disease and its determination has been proposed as one method of improving the prediction of the risk of cardiovascular events. CRP was determined in 150 hypertensive patients aged 30-59 years and 30 apparently healthy normotensive individuals matched for age and socioeconomic status by ELISA technique. Atherogenic index (LDL-C/HDL-C) and coronary heart disease risk (HDL-C/TC) were also calculated from the lipid profile. Among the hypertensive patients, only 1 (1.2%) female had a dangerous coronary heart disease risk, while 14 (9.3%) (6 males and 8 females) were at high risk of CHD and only 16 (10.7%) (11 males and 5 females) had probable protection against CHD. Hypertensive patients were significantly (p < 0.05) heavier than the normotensive patients (28.34 ± 4.40kg/m vs. 25.79 ± 2.91kg/m), with significantly higher atherogenic indices and CRP. Among the hypertensive patients, CRP positively correlated with atherogenic index (r = 0.551, p < 0.05) and CHD risk (r = 0.589, p < 0.05). However, in normotensive patients, CRP was positively correlated with atherogenic index (r = 0.492, p < 0.01) but negatively correlated with CHD risk (r = -0.475, p < 0.01). In conclusion, hypertensive Nigerians have significantly higher CRP than their normotensive counterparts, which correlates with CHD risk.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122258578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ufuk Yetk n, C. Özbek, M. Akyüz, A. Çallı, Ali Gürbüz
Left atrial ball thrombus appears to be uncommon. Ball thrombi of the left atrium are usually observed with mitral valve disease.In this study ,we report a case of successful mitral valve repair and ring annuloplasty in a case with giant left atrial thrombus. Removal of the ball thrombus and mitral valve repair were performed simultaneously.Early diagnosis and emergent surgical intervention are mandatory for giant left atrial thrombus
{"title":"Successful Mitral Valve Repair and Ring Annuloplasty In A Case With Giant Left Atrial Thrombus","authors":"Ufuk Yetk n, C. Özbek, M. Akyüz, A. Çallı, Ali Gürbüz","doi":"10.5580/2119","DOIUrl":"https://doi.org/10.5580/2119","url":null,"abstract":"Left atrial ball thrombus appears to be uncommon. Ball thrombi of the left atrium are usually observed with mitral valve disease.In this study ,we report a case of successful mitral valve repair and ring annuloplasty in a case with giant left atrial thrombus. Removal of the ball thrombus and mitral valve repair were performed simultaneously.Early diagnosis and emergent surgical intervention are mandatory for giant left atrial thrombus","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122303382","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Globally, Type 2 diabetes mellitus (T2DM) continues to prove a huge challenge to patients and clinicians. Treatment of T2DM has traditionally been focused on the regulation of sugar in the blood with diet and drugs. Substantial epidemiological data has demonstrated since the 1970s that cardiovascular diseases (CVD) constitute the primary cause of morbidity and mortality in patients with diabetes. This systematic review was aimed at using clinical trials on published literature to pull out evidence based medicine to support or discount the mortality benefits of statin therapy in T2DM patients. From the clinical trials reviewed, statin therapy in non diabetic and T2DM showed varying degrees of reduction in CHD events. Pravastatin therapy reduced the risk among all patients from 15.9 % to 12.3% (relative risk reduction (RRR) 24%). In diabetics, the RRR was 19%. Same therapy reduced the risk of stroke from 9.9% to 6.3% in diabetic group. Another study observed in their results a significant reduction in mortality (1328:12.9%) deaths among 10,269 patients in the simvastatin group versus 1507: 14.7% among 10,267 patients in the placebo group. Other studies also reported significant or near significant reduction in mortality or death rate. Artovastatin reduced acute CHD events by 36%, coronary revascularization by 31% and rate of stroke by 48%. Pravastatin on the other hand showed 25% reduction of risk of coronary events (CHD, death, non fatal myocardial Infarction (MI) and coronary artery by pass graft (CABG)). Another study showed that patients with T2DM and other risk factors of coronary artery disease or retinopathy had a 35% relative risk reduction in CVD when Atorvaststin 10mg was given daily which was similar to a 33% relative risk reduction in CVD with Simvastatin 40mg. Other clinical trials showed significant evidence that the pharmacological treatment with statins reduced mortality and morbidity associated with CVD especially those who are already at higher risk of CHD events, such as patients with T2DM while long term treatment is often necessary.
{"title":"Statins in the Treatment of Type 2 Diabetes Mellitus: A Systematic Review.","authors":"C. Anyanwu, C. Nosiri","doi":"10.5580/2443","DOIUrl":"https://doi.org/10.5580/2443","url":null,"abstract":"Globally, Type 2 diabetes mellitus (T2DM) continues to prove a huge challenge to patients and clinicians. Treatment of T2DM has traditionally been focused on the regulation of sugar in the blood with diet and drugs. Substantial epidemiological data has demonstrated since the 1970s that cardiovascular diseases (CVD) constitute the primary cause of morbidity and mortality in patients with diabetes. This systematic review was aimed at using clinical trials on published literature to pull out evidence based medicine to support or discount the mortality benefits of statin therapy in T2DM patients. From the clinical trials reviewed, statin therapy in non diabetic and T2DM showed varying degrees of reduction in CHD events. Pravastatin therapy reduced the risk among all patients from 15.9 % to 12.3% (relative risk reduction (RRR) 24%). In diabetics, the RRR was 19%. Same therapy reduced the risk of stroke from 9.9% to 6.3% in diabetic group. Another study observed in their results a significant reduction in mortality (1328:12.9%) deaths among 10,269 patients in the simvastatin group versus 1507: 14.7% among 10,267 patients in the placebo group. Other studies also reported significant or near significant reduction in mortality or death rate. Artovastatin reduced acute CHD events by 36%, coronary revascularization by 31% and rate of stroke by 48%. Pravastatin on the other hand showed 25% reduction of risk of coronary events (CHD, death, non fatal myocardial Infarction (MI) and coronary artery by pass graft (CABG)). Another study showed that patients with T2DM and other risk factors of coronary artery disease or retinopathy had a 35% relative risk reduction in CVD when Atorvaststin 10mg was given daily which was similar to a 33% relative risk reduction in CVD with Simvastatin 40mg. Other clinical trials showed significant evidence that the pharmacological treatment with statins reduced mortality and morbidity associated with CVD especially those who are already at higher risk of CHD events, such as patients with T2DM while long term treatment is often necessary.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126082225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ay egül Sars lmaz, Melda Apayd n, U. Yetkin, Ergun Öziz, M. Varer, smail Yürekli, E. Uluç, A. Gürbüz
Portal vein aneurysm is a rare clinical entity. We describe a case of portal vein aneurysm due to traumatic etiology. Our patient had no signs suggestive of portal hypertension; the lesion was incidentally detected by ultrasound. It appears that these aneurysms can be found at any age and that there is no sexual preference. This pathology is increasingly encountered with the frequent use of radiological imaging modalities. INTRODUCTION Portal vein aneurysm is a rare clinical entity, with only 41 published cases in the English-language literature. Twentyfive of them were congenital(1). Portal venous aneurysms are described as focal dilatations of the portal venous system(2).Generally it was incidentally diagnosed during an investigation for dyspepsia(1). CASE PRESENTATION Our case was a 65-year-old male. He was suffering from flatulance and dyspepsia for 2 years. His past medical history was significant for a blunt trauma to the right upper quadrant of the abdomen he had experienced 19 years ago due to a traffic accident. Upper abdominal ultrasound imaging was carried out for a possible diagnosis of cholelithiasis. A venous aneurysm of 28x24 mm corresponding to the proximal zone of left branch of portal vein next to the falciform ligament. (Figures 1 and 2). Figure 1 Figure 1 Portal vein aneurysm due to traumatic etiology 2 of 4 Figure 2 Figure 2 Color Doppler ultrasound imaging revealed venous aneurysmal dilation with continuous flow pattern as in the case with portal flow (Figure 3).
{"title":"Portal vein aneurysm due to traumatic etiology","authors":"Ay egül Sars lmaz, Melda Apayd n, U. Yetkin, Ergun Öziz, M. Varer, smail Yürekli, E. Uluç, A. Gürbüz","doi":"10.5580/f7d","DOIUrl":"https://doi.org/10.5580/f7d","url":null,"abstract":"Portal vein aneurysm is a rare clinical entity. We describe a case of portal vein aneurysm due to traumatic etiology. Our patient had no signs suggestive of portal hypertension; the lesion was incidentally detected by ultrasound. It appears that these aneurysms can be found at any age and that there is no sexual preference. This pathology is increasingly encountered with the frequent use of radiological imaging modalities. INTRODUCTION Portal vein aneurysm is a rare clinical entity, with only 41 published cases in the English-language literature. Twentyfive of them were congenital(1). Portal venous aneurysms are described as focal dilatations of the portal venous system(2).Generally it was incidentally diagnosed during an investigation for dyspepsia(1). CASE PRESENTATION Our case was a 65-year-old male. He was suffering from flatulance and dyspepsia for 2 years. His past medical history was significant for a blunt trauma to the right upper quadrant of the abdomen he had experienced 19 years ago due to a traffic accident. Upper abdominal ultrasound imaging was carried out for a possible diagnosis of cholelithiasis. A venous aneurysm of 28x24 mm corresponding to the proximal zone of left branch of portal vein next to the falciform ligament. (Figures 1 and 2). Figure 1 Figure 1 Portal vein aneurysm due to traumatic etiology 2 of 4 Figure 2 Figure 2 Color Doppler ultrasound imaging revealed venous aneurysmal dilation with continuous flow pattern as in the case with portal flow (Figure 3).","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"6 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114102636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A. G. Ciss, O. Diarra, A. Ndiaye, P. A. Dieng, P. S. Ba, M. Ba, S. Beye, O. Kane, I. Diop, M. Ndiaye
A 13-year old female was referred from paediatric department for severe dyspnoea (stage III NYHA), with swelling of the face and the lower limbs. The physical examination revealed bad general health status and a clinical anaemia. There was also an enlargement of the jugular veins and the liver. The heart auscultation allowed a diagnosis of a pulmonary stenosis bruit, which was not varying with the changes of postures. The patient did not present any neuro-endocrine clinical signs or skin problems.The transthoracic echocardiography (TTE) revealed a cardiac tumour mimicking a myxoma was implanted on the antero lateral side of the right ventricular wall with an expansion into the outflow tract. The patient was operated within 48 hours following her admission. On CPB the tumour looking like myxoma was excised through a right atriotomy. The tricuspid valve was normal. Cross clamping time was 15 minutes. The pathological examination showed a myxoma-like tumour with two lobes measuring 4.2 x 2.3 centimeters. The evolution was simple; the post operative TTE check ups were satisfactoryRight ventricular myxoma protruding into the outflow tract is rare and can present with right heart failure. Surgical excision is seldom possible.We emphasize the importance of periodic follow up of this young patient with TEE for early detection of recurrence.
一名13岁女性因严重呼吸困难(III期NYHA)从儿科转介，面部和下肢肿胀。体检显示一般健康状况不佳和临床贫血。颈静脉和肝脏也有肿大。心脏听诊可诊断肺动脉狭窄，且不随体位变化而变化。患者未出现任何神经内分泌临床症状或皮肤问题。经胸超声心动图(TTE)显示一个类似黏液瘤的心脏肿瘤植入右心室壁前外侧，并扩张至流出道。患者入院后48小时内接受手术治疗。在CPB上，通过右心房切开术切除了看起来像粘液瘤的肿瘤。三尖瓣正常。交叉夹持时间15分钟。病理检查为黏液瘤样肿瘤，两叶大小为4.2 x 2.3厘米。进化过程很简单;术后TTE检查令人满意。右心室黏液瘤突入流出道是罕见的，可表现为右心衰。手术切除很少可行。我们强调对这名年轻TEE患者进行定期随访以早期发现复发的重要性。
{"title":"Right ventricle myxoma obstructing partially right ventricular outflow tract","authors":"A. G. Ciss, O. Diarra, A. Ndiaye, P. A. Dieng, P. S. Ba, M. Ba, S. Beye, O. Kane, I. Diop, M. Ndiaye","doi":"10.5580/10f2","DOIUrl":"https://doi.org/10.5580/10f2","url":null,"abstract":"A 13-year old female was referred from paediatric department for severe dyspnoea (stage III NYHA), with swelling of the face and the lower limbs. The physical examination revealed bad general health status and a clinical anaemia. There was also an enlargement of the jugular veins and the liver. The heart auscultation allowed a diagnosis of a pulmonary stenosis bruit, which was not varying with the changes of postures. The patient did not present any neuro-endocrine clinical signs or skin problems.The transthoracic echocardiography (TTE) revealed a cardiac tumour mimicking a myxoma was implanted on the antero lateral side of the right ventricular wall with an expansion into the outflow tract. The patient was operated within 48 hours following her admission. On CPB the tumour looking like myxoma was excised through a right atriotomy. The tricuspid valve was normal. Cross clamping time was 15 minutes. The pathological examination showed a myxoma-like tumour with two lobes measuring 4.2 x 2.3 centimeters. The evolution was simple; the post operative TTE check ups were satisfactoryRight ventricular myxoma protruding into the outflow tract is rare and can present with right heart failure. Surgical excision is seldom possible.We emphasize the importance of periodic follow up of this young patient with TEE for early detection of recurrence.","PeriodicalId":330833,"journal":{"name":"The Internet Journal of Thoracic and Cardiovascular Surgery","volume":"20 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123787100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：